SI1119571T1 - Tricyclic delta3-piperidines as alpha2-antagonists - Google Patents

Tricyclic delta3-piperidines as alpha2-antagonists

Info

Publication number
SI1119571T1
SI1119571T1 SI9930264T SI9930264T SI1119571T1 SI 1119571 T1 SI1119571 T1 SI 1119571T1 SI 9930264 T SI9930264 T SI 9930264T SI 9930264 T SI9930264 T SI 9930264T SI 1119571 T1 SI1119571 T1 SI 1119571T1
Authority
SI
Slovenia
Prior art keywords
alpha2
piperidines
antagonists
delta3
tricyclic
Prior art date
Application number
SI9930264T
Other languages
English (en)
Slovenian (sl)
Inventor
Ludo Edmond J. Janssen Pharmaceutica N.V. KENNIS
DEN KEYBUS F.M.A. Janssen Pharmaceutica N.V. VAN
Josephus C. Janssen Pharmaceutica N.V. MERTENS
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of SI1119571T1 publication Critical patent/SI1119571T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
SI9930264T 1998-10-06 1999-10-01 Tricyclic delta3-piperidines as alpha2-antagonists SI1119571T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98203370 1998-10-06
EP99950627A EP1119571B1 (en) 1998-10-06 1999-10-01 Tricyclic delta3-piperidines as alpha2-antagonists
PCT/EP1999/007419 WO2000020421A2 (en) 1998-10-06 1999-10-01 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS

Publications (1)

Publication Number Publication Date
SI1119571T1 true SI1119571T1 (en) 2003-08-31

Family

ID=8234191

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9930264T SI1119571T1 (en) 1998-10-06 1999-10-01 Tricyclic delta3-piperidines as alpha2-antagonists

Country Status (31)

Country Link
US (1) US6495555B1 (xx)
EP (1) EP1119571B1 (xx)
JP (1) JP4590101B2 (xx)
KR (1) KR20010071843A (xx)
CN (1) CN1131230C (xx)
AR (1) AR024216A1 (xx)
AT (1) ATE232869T1 (xx)
AU (1) AU760502B2 (xx)
BG (1) BG64872B1 (xx)
BR (1) BR9913507A (xx)
CA (1) CA2345622C (xx)
CZ (1) CZ20011104A3 (xx)
DE (1) DE69905478T2 (xx)
DK (1) DK1119571T3 (xx)
EE (1) EE04770B1 (xx)
ES (1) ES2193751T3 (xx)
HK (1) HK1038010A1 (xx)
HU (1) HUP0104002A3 (xx)
ID (1) ID28032A (xx)
IL (1) IL142443A0 (xx)
NO (1) NO20011270D0 (xx)
NZ (1) NZ510115A (xx)
PL (1) PL347894A1 (xx)
PT (1) PT1119571E (xx)
RU (1) RU2230744C2 (xx)
SI (1) SI1119571T1 (xx)
SK (1) SK285585B6 (xx)
TR (1) TR200100952T2 (xx)
TW (1) TWI248441B (xx)
UA (1) UA69420C2 (xx)
WO (1) WO2000020421A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE04680B1 (et) * 1998-10-06 2006-08-15 Janssen Pharmaceutica N.V. Tritsklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod
CA2480266C (en) * 2002-04-03 2011-07-12 Orion Corporation Use of an alpha2-adrenoreceptor antagonist for cns-related diseases
AU2005233456A1 (en) 2004-04-12 2005-10-27 Taisho Pharmaceutical Co., Ltd. Cyclic amine compound
EP1775283A4 (en) * 2004-07-14 2008-12-10 Japan Tobacco Inc 3-AMINOBENZAMIDE COMPOUND AND INHIBITORS OF THE ACTIVITY OF VANILLOID RECEPTOR 1 (VR1)
BRPI0513286A (pt) * 2004-07-15 2008-05-06 Japan Tobacco Inc compostos de benzamida condensada e inibidores de atividade de receptor vanilóide subtipo (vr1), suas composições farmacêuticas, pacote comercial, fármaco e respectivos usos
US7906508B2 (en) * 2005-12-28 2011-03-15 Japan Tobacco Inc. 3,4-dihydrobenzoxazine compounds and inhibitors of vanilloid receptor subtype 1 (VRI) activity
CN102459251B (zh) 2009-05-14 2015-05-20 詹森药业有限公司 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物
AP2016009303A0 (en) 2013-12-19 2016-06-30 Bayer Pharma AG Substituted piperidinyl-tetrahydroquinolines
JOP20200052A1 (ar) 2013-12-19 2017-06-16 Bayer Pharma AG بيبريدينيل تتراهيدرو كوينولينات مستبدلة واستخدامها كمعضدات مستقبل أدريني ألفا- 2c
JP2017503778A (ja) 2013-12-19 2017-02-02 バイエル ファーマ アクチエンゲゼルシャフト アドレナリン受容体α２Ｃ拮抗薬としての置換されたビピペリジニル誘導体
CN114276359B (zh) * 2022-01-05 2023-05-05 浙江大学 一种1,2,3,4-四氢苯并[4,5]呋喃[2,3-c]吡啶衍生物的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522959A1 (de) * 1985-06-27 1987-01-08 Merck Patent Gmbh Indolderivate
US4673680A (en) * 1985-09-18 1987-06-16 Pendleton Robert G α2 -adrenergic receptor antagonists as modifiers of gastrointestinal motility
US4985422A (en) * 1988-04-27 1991-01-15 Glaxo Group Limited Lactam derivatives
US4971974A (en) * 1988-06-16 1990-11-20 Neurex Corporation Benzothiophenes as appetite suppressants
US5100891A (en) * 1991-01-18 1992-03-31 Hoechst-Roussel Pharmaceuticals Inc. Substituted 1,2,3,4-tetrahydrocyclopent[b]indoles, 1,2,3,3a,4,8a-hexahydrocyclopent[B]indoles and related compounds
CZ194499A3 (cs) * 1996-12-06 1999-11-17 Abbott Laboratories Benzopyranopyrolové a benzopyranopyridín alfa-1 adrenergické sloučeniny
KR100588249B1 (ko) * 1997-12-25 2006-06-13 메이지 세이카 가부시키가이샤 테트라하이드로벤즈인돌 유도체
EE04680B1 (et) * 1998-10-06 2006-08-15 Janssen Pharmaceutica N.V. Tritsklilised 3-piperidiinid, nende valmistamismeetod, kasutamine, farmatseutiline kompositsioon ja selle valmistamismeetod

Also Published As

Publication number Publication date
DE69905478T2 (de) 2004-03-18
UA69420C2 (uk) 2004-09-15
CN1332744A (zh) 2002-01-23
JP4590101B2 (ja) 2010-12-01
AR024216A1 (es) 2002-09-25
WO2000020421A3 (en) 2000-08-03
NO20011270L (no) 2001-03-13
ATE232869T1 (de) 2003-03-15
EE200100209A (et) 2002-06-17
TWI248441B (en) 2006-02-01
EP1119571A2 (en) 2001-08-01
BR9913507A (pt) 2001-06-05
JP2002526545A (ja) 2002-08-20
AU6334199A (en) 2000-04-26
US6495555B1 (en) 2002-12-17
DE69905478D1 (de) 2003-03-27
PT1119571E (pt) 2003-06-30
WO2000020421A2 (en) 2000-04-13
ID28032A (id) 2001-05-03
CA2345622A1 (en) 2000-04-13
RU2230744C2 (ru) 2004-06-20
HUP0104002A3 (en) 2003-12-29
PL347894A1 (en) 2002-04-22
NO20011270D0 (no) 2001-03-13
AU760502B2 (en) 2003-05-15
SK285585B6 (sk) 2007-04-05
TR200100952T2 (tr) 2001-10-22
BG64872B1 (bg) 2006-07-31
IL142443A0 (en) 2002-03-10
ES2193751T3 (es) 2003-11-01
EP1119571B1 (en) 2003-02-19
SK4322001A3 (en) 2002-01-07
HUP0104002A2 (hu) 2002-03-28
CN1131230C (zh) 2003-12-17
DK1119571T3 (da) 2003-05-26
EE04770B1 (et) 2007-02-15
BG105332A (en) 2001-11-30
CZ20011104A3 (cs) 2001-12-12
KR20010071843A (ko) 2001-07-31
NZ510115A (en) 2002-11-26
CA2345622C (en) 2007-12-04
HK1038010A1 (en) 2002-03-01

Similar Documents

Publication Publication Date Title
PL345589A1 (en) β-CARBOLINE COMPOUNDS
IL137511A0 (en) Novel tricyclic compound
GB9804734D0 (en) Compounds
GB2338672B (en) Toolholder
EA199900301A3 (ru) Замещенные трициклические соединения.
GB9804175D0 (en) Compounds
PL345283A1 (en) Biphenyl derivatives
EA199900304A3 (ru) Замещенные трициклические соединения.
HK1038010A1 (en) Tricyclic delta3-piperidines as alpha2-antagonists
GB9816729D0 (en) Substituted cyclohexylaminopyrimidines
HK1039937A1 (zh) 取代的3-硫代氨基甲酰基吡唑類化合物
CZ20012041A3 (cs) Benzofuranové deriváty
IL142444A0 (en) TRICYCLIC δ3-PIPERIDINES AS PHARMACEUTICALS
PL343598A1 (en) Biphenyl derivatives
PL347397A1 (en) Substituted 3-aryl-pyrazoles
GB9809823D0 (en) Compounds
PL345866A1 (en) Substituted cyclooctadepsipeptides
HK1039335A1 (zh) 取代的苯甲酰基環已二酮類化合物
GB9810876D0 (en) Compounds
EP1105133A4 (en) TRICYCLIC CONNECTIONS
GB2336672B (en) Level
GB9801712D0 (en) Compounds
GB9809217D0 (en) Compounds
TW342936U (en) Level
GB9817401D0 (en) Novel compunds